Solex Energy has scheduled its 12th Annual General Meeting for September 22, 2026. The meeting will address key corporate actions including a proposed dividend and enhanced borrowing limits.

The company proposes a final dividend of ₹0.55 per equity share of face value ₹10 each for the financial year ended March 31, 2026. Shareholders on record as of September 15, 2026 will be eligible for the payout if approved.

What the Numbers Show

The proposed borrowing limit of ₹2,000 crore represents a substantial expansion in financial flexibility. This ceiling allows the company to raise funds from various sources, including banks and financial institutions, beyond its paid-up share capital and free reserves. The move aligns with the company's stated objectives to support capital expenditure and strategic investments.

Governance and Remuneration

The Board seeks approval for the re-appointment of Dr. Chetan Shah as Chairman and Managing Director for a further term of three years, commencing August 6, 2027. His remuneration is capped at ₹50 lakh per month, with total benefits not exceeding ₹6 crore per annum.

Mr. Piyush Chandak is also up for re-appointment as Whole-Time Director for three years starting September 1, 2027. His monthly CTC is set at ₹2.5 lakh, with an annual cap of ₹30 lakh on total remuneration and benefits.

Related Party Transactions

Shareholders will vote on material related party transactions with subsidiary Solex Green Energy Private Limited. The proposed aggregate value for FY27 is capped at ₹300 crore. These transactions include the sale and purchase of goods and services, expected to constitute 18.54% of the listed entity's annual consolidated turnover from the preceding year.

Voting Details

The remote e-voting period begins on September 19, 2026, at 9:00 am and ends on September 21, 2026, at 5:00 pm. The register of members will remain closed from September 16 to September 21, 2026.

Solex Energy reported a year-on-year decline in net profit of 33% to ₹8.3 crore for the first quarter of FY27, despite a marginal rise in revenue. The contraction in profitability was driven by higher depreciation and finance costs associated with expanded capacity.

Total revenue stood at ₹265.6 crore in Q1FY27, up 1.8% from ₹261 crore in the same period last year. EBITDA fell to ₹33.8 crore from ₹42.7 crore, resulting in a margin compression from 16.4% to 12.7%.

Financial Performance

The company attributed the profit dip to structural cost increases rather than operational weakness. Depreciation and amortization more than doubled to ₹10.2 crore from ₹4.3 crore, reflecting the full-quarter impact of Line 3 and Line 4 commissioned in November 2025. Finance costs rose to ₹12.5 crore from ₹5.4 crore due to higher working capital deployment via fund-based limits.

Profit before tax stood at ₹11.1 crore. Earnings per share were reported at ₹7.39.

What the Numbers Show

The divergence between stable revenue and declining margins highlights the impact of fixed costs on Solex’s current scale. With revenue growth limited to 1.8%, the company absorbed a ₹5.9 crore increase in depreciation and a ₹7.1 crore rise in finance costs. This suggests that until capacity utilization improves significantly in the second half, operating leverage will remain muted as fixed expenses outpace top-line growth.

Order Book and Outlook

Management highlighted an order book visibility of approximately ₹3,400 crore, comprising confirmed purchase orders, signed MSAs, and advanced-stage discussions. The company secured a new work order worth ₹42.47 crore in August 2026 for N-type TOPCon modules, adding to a pipeline of ₹845.84 crore targeted for execution by December 31, 2026.

Chairman Dr. Chetan Shah noted that the business is inherently second-half weighted due to seasonal utility-scale project execution. He clarified that recent delivery delays were timing shifts rather than cancellations, driven by industry-wide wait-and-watch behavior following ALMM-2 regulatory clarifications.

Strategic Initiatives

Solex is advancing its backward integration plans with a 2.2 GW N-type TOPCon+ cell manufacturing line, targeted for commissioning by end-2027. The project requires approximately ₹700 crore in debt and ₹350 crore in equity. The company also listed its shares on the BSE main board in August 2026, broadening its investor base without raising fresh capital.

For FY27, management maintains its revenue guidance and expects PAT margins in the range of 5% to 6%, contingent on higher utilization rates in the latter half of the fiscal year.